NanoCross™ Elite AB14W025210150 (UDI 00821684066362)Recalls & reported problems
Ev3, Inc · PTA AB14W025210150 NANOCROSS 014 V04 · Class 2
All models of NanoCross Elite (63)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00821684066362), received between Jul 19, 2017 and Oct 24, 2017 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Material Deformation” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Material Deformation2
Patient problems
- No Consequences Or Impact To Patient2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionOct 24, 2017Material Deformation; Material Deformation
THE PHYSICIAN WAS USING A NANOCROSS ELITE PTA BALLOON TO TREAT A SEVERELY CALCIFIED AND MODERATELY TORTUOUS PROXIMAL COMMON ILIAC ARTERY LESION EXHIBITING CHRONIC TOTAL OCCLUSION. THE DEVICE WAS REMOVED FROM ITS PACKAGING AND INSPECTED WITH NO ISSUES NOTED. THE DEVICE WAS PREPPED PER THE IFU. THE DEVICE DID NOT PASS THROUGH A PREVIOUSLY DEPLOYED STENT. RESISTANCE WAS NOT ENCOUNTERED AND NO EXCESSIVE FORCE WAS USED. THE BALLOON WAS INFLATED USING A NON-MEDTRONIC INFLATION DEVICE AND A 50/50 CONTRAST SALINE MIX. THE BALLOON WAS USED TO INFLATE THE SUBINTIMAL SPACE OF THE COMMON ILIAC / AORTA. NO ISSUES WERE NOTED INFLATING OR DEFLATING THE BALLOON. THE PHYSICIAN EXPERIENCED REMOVAL DIFFICULTIES. THE BALLOON WAS FLUSHED IN AN ATTEMPT TO LUBRICATE THE BALLOON WITH NO SUCCESS. THE BALLOON DID NOT CATCH ON THE SHEATH DURING REMOVAL. THE PHYSICIAN WAS ABLE TO FORCEFULLY REMOVE THE BALLOON AND THE WIRE PLACEMENT WAS NOT LOST. NO PATIENT INJURY WAS REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6975138 ↗MalfunctionJul 19, 2017Material Deformation; Material Deformation
PHYSICIAN INTENDED TO USE A NANOCROSS ELITE PTA BALLOON. THERE WAS NO DAMAGE NOTED TO PACKAGING, NOR ANY ISSUES IDENTIFIED WHEN REMOVING THE DEVICE FROM THE HOOP/TRAY. IFU WAS FOLLOWED AND DEVICE WAS PREPPED WITHOUT ISSUE. IT WAS REPORTED THAT MODERATE RESISTANCE WAS FELT DURING ADVANCEMENT. THE PHYSICIAN REPORTED THAT THE FIRST BALLOON WOULD NOT ADVANCE OVER THE WIRE PAST THE LESION, PERHAPS IT WAS TOO BIG, BUT DIFFICULTY WAS EXPERIENCED GETTING IT BACK OFF THE WIRE. THE LESION WAS THEN PRE-DILATED USING A 2MM BALLOON AND TRIED A DIFFERENT WIRE. THE BALLOON WAS STILL UNABLE TO CROSS, AND WHEN THE PHYSICIAN ATTEMPTED TO REMOVE THE BALLOON, THE DELIVERY CATHETER STRETCHED ENTIRELY AND TORE OFF ON THE WIRE. THE RADIO MARKERS DISLODGED IN THE SHEATH. THE PHYSICIAN THEN REMOVED ALL OF THE DEVICES AND ABORTED THE PROCEDURE. IT WAS REPORTED THAT NO COMPONENTS EMBOLIZED. NO PATIENT INFORMATION OF LESION MORPHOLOGY INFORMATION WAS PROVIDED. NO PATIENT INJURY REPORTED. CONFIRMATION RECEIVED INDICATES THAT FOR THE FIRST BALLOON THE ALLEGATION IS THAT IT WOULD NOT CROSS. THE SECOND BALLOON HAD THE MARKERS DISLODGE IN THE SHEATH.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6727256 ↗
Other Catheter, angioplasty, peripheral, transluminal devices
- Coyote™ ES H74939135152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal879 reports
- Coyote™ ES H74939135204010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal585 reports
- Coyote™ ES H74939135202010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal437 reports
- Coyote™ ES H74939135304010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal384 reports
- Coyote™ ES H74939135404010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal293 reports
- Coyote™ ES H74939134152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal279 reports
- Coyote™ H74939185202210Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal200 reports
- Coyote™ ES H74939135254010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal127 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page